| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 01/17/2008 | WO2007105113A3 Use of crf1 receptor antagonists for preparing a drug for treating metabolic syndrome and/or obesity and/or dyslipoproteinemia |
| 01/17/2008 | WO2007076371A3 Hydrophobic core carrier compositions for delivery of therapeutic agents, methods of making and using the same |
| 01/17/2008 | WO2007067341A3 Compositions and methods for increasing insulin sensitivity |
| 01/17/2008 | WO2006137789A8 Quinoline 3 -sulfonate esters as NK3 receptor modulators |
| 01/17/2008 | US20080015257 Compositions and methods for reducing body fat |
| 01/17/2008 | US20080015254 5-[3-(2,6-Dimethylbenzyloxy)-phenyl]-pent-4-enoic acid ethyl ester; insulin resistance syndrome, diabetes, cachexia, hyperlipidemia, fatty liver disease, obesity, atherosclerosis, arteriosclerosis; side effects reduction; orally active |
| 01/17/2008 | US20080015253 Peroxisome Proliferator Activated Receptors modulators; ethyl (R,S)-2-(4-trifluoromethylphenyl)oxypent-4-enoate; dyslipidemia, atherosclerosis and diabetes |
| 01/17/2008 | US20080015251 Means and method for treating lipotoxicity and other metabolically related phenomena |
| 01/17/2008 | US20080015247 quercetin, vitamin B3, and vitamin C as only ingredients, specified weight ratio; dietary supplement or a pharmaceutical formulation; free radical induced diseases |
| 01/17/2008 | US20080015242 Use of N-[3-[2-[2-(3-methylindazol-6-yloxy)ethylamino]-1-hydroxyethyl]phenyl]methanesulfonamide or salt for treating diabetes, obesity, hyperlipidemia and urinary incontinence; drug interaction side effect reduction |
| 01/17/2008 | US20080015240 Acid Salt of Benzimidazole Derivative and Crystal Thereof |
| 01/17/2008 | US20080015238 Cycloalkylmethoxy-substituted acetic acid derivatives, processes for their preparation and their use as pharmaceuticals |
| 01/17/2008 | US20080015230 Heterocyclic derivatives and their use as therapeutic agents |
| 01/17/2008 | US20080015227 Inhibitors of diacylglycerol O-acyltransferase type 1 enzyme |
| 01/17/2008 | US20080015218 Antioxidant combinations for use in ruminant feed rations having a fat source |
| 01/17/2008 | US20080015217 Antioxidant combinations for use in ruminant feed rations |
| 01/17/2008 | US20080015209 Compounds for the treatment of metabolic disorders |
| 01/17/2008 | US20080015203 Such as 3-[(1S)-2-hydroxy-1-methylethoxy]-5-[4-(methylsulfonyl)phenoxy]-N-1,3-thiazol-2-ylbenzamide; glucokinases (Glk) |
| 01/17/2008 | US20080015195 Novel Heteroaromatic Inhibitors of Fructose-1,6-Bisphosphatase |
| 01/17/2008 | US20080015193 Certain azoles exhibiting ATP-utilizing enzyme inhibitory activity, compositions, and uses thereof |
| 01/17/2008 | US20080015185 N-heterocyclic inhibitors of tnf-alpha expression |
| 01/17/2008 | US20080015183 Substituted quinazolin-4-ylamine analogues |
| 01/17/2008 | US20080015180 Methods and compositions for treating amyloid-related diseases |
| 01/17/2008 | US20080015177 S1P receptor modulating compounds and use thereof |
| 01/17/2008 | US20080015176 such as dabigatran etexilate in children; congenital heart disease, shunt or catheter thrombosis, pulmonary embolism, stroke in pregnant girls; pediatrics |
| 01/17/2008 | US20080015175 Nontoxic; inhibition of interleukin-1 beta -converting enzyme |
| 01/17/2008 | US20080015174 Metabolic Disease Treatments |
| 01/17/2008 | US20080015172 Caspase inhibitors and uses thereof |
| 01/17/2008 | US20080015169 Amino-methyl substituted tetracycline compounds |
| 01/17/2008 | US20080015152 Therapeutic amino acid sequences for use in treatment and prevention of viral, infectious, cancerous, diabetic, incontinent, hypertensive, eating and nervous system disorders |
| 01/17/2008 | US20080015146 e.g. 3-Amino-1-[(S)-2-(3-tert-butyl-[1,2,4]oxadiazol-5-yl)-pyrrolidin-1-yl]-4-(2,4,5-trifluorophenyl)-butan-1-one; dipeptidyl-peptidase inhibitor; antidiabetic, hypoglycemic agent; metabolic disorders, obesity, non-insulin dependent diabetes |
| 01/17/2008 | US20080015144 Glp- (9-36) Methods and Compositions |
| 01/17/2008 | US20080014623 Nutrient absorption enhancing compositions and methods |
| 01/17/2008 | US20080014282 Therapeutic, Nutraceutical and Cosmetic Applications for Eggshell Membrane and Processed Eggshell Membrane Preparations |
| 01/17/2008 | US20080014273 Equine whole food supplements |
| 01/17/2008 | US20080014270 Methods for improved lipid metabolism and basal metabolic rate with lactoferrin |
| 01/17/2008 | US20080014266 Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent |
| 01/17/2008 | US20080014246 Methods and compounds for controlled release of recombinant parvovirus vectors |
| 01/17/2008 | US20080014228 Solid form |
| 01/17/2008 | US20080014227 Heterocyclic compounds based on n6-substituted adenine, methods of their preparation, their use for preparation of drugs, cosmetic preparations and growth regulators, pharmaceutical preparations, cosmetic preparations and growth regulators containing these compounds |
| 01/17/2008 | US20080014218 Use of tight junction agonists to facilitate pulmonary delivery of therapeutic agents |
| 01/17/2008 | US20080014189 Diaminotriazoles useful as inhibitors of protein kinases |
| 01/17/2008 | US20080014178 Method for Stimulating Mammalian Cells and Mammalian Cell |
| 01/17/2008 | DE102006031813A1 Basische Acetophenone als Hemmstoffe von NO-Synthasen Basic acetophenones as inhibitors of NO synthases |
| 01/17/2008 | CA2690277A1 Pyrrolopyrimidines for pharmaceutical compositions |
| 01/17/2008 | CA2659590A1 Irreversible protein tyrosine kinases inhibitors and the preparation methods and uses thereof |
| 01/17/2008 | CA2658069A1 Medicagenic acid saponin and uses thereof |
| 01/17/2008 | CA2657623A1 Bridged diazepan orexin receptor antagonists |
| 01/17/2008 | CA2657335A1 Use of ampk-activating imidazole derivatives, preparation process therefor and pharmaceutical compositions comprising them |
| 01/17/2008 | CA2657078A1 11beta-hydroxysteroid dehydrogenase type 1 active compounds |
| 01/17/2008 | CA2657069A1 4-piperidylbenzamides as 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors |
| 01/16/2008 | EP1878800A1 Method for evaluating compound using barlp and substance for suppressing eating and body weight |
| 01/16/2008 | EP1878748A2 Identification of unique binding interactions between certain antibodies and the human B7.1 and B7.2 costimulatory antigens |
| 01/16/2008 | EP1878734A1 Novel lactam compound |
| 01/16/2008 | EP1878727A1 2-aminoquinazoline derivatives |
| 01/16/2008 | EP1878721A1 4-Piperidylbenzamides as 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors |
| 01/16/2008 | EP1878426A1 Granular preparation containing biguanide compound |
| 01/16/2008 | EP1878425A1 Transdermal absorption accelerator |
| 01/16/2008 | EP1877373A2 Biphenylazetidinone cholesterol absorption inhibitors |
| 01/16/2008 | EP1877369A2 Inhibitors of microsomal triglyceride transfer protein and apo-b secretion |
| 01/16/2008 | EP1877099A2 Peg and polysialic lysosomal enzyme conjugates via acid labile linkers for therapeutic targeting |
| 01/16/2008 | EP1877075A2 Antibodies to myostatin |
| 01/16/2008 | EP1755593B1 Naphthalene derivatives useful as histamine-3-receptor ligands |
| 01/16/2008 | EP1694673B1 Thiazole derivates |
| 01/16/2008 | EP1492793B1 New-4-(pyrrolopyrimidin-6-yl)benzenesulphonamide derivatives |
| 01/16/2008 | EP1317432B1 Piperidine derivatives for use as 2,3-oxidosqualene-lanosterol cyclase inhibitors |
| 01/16/2008 | EP1305311B1 Tartrate salt of thiazolidinedione derivative |
| 01/16/2008 | EP1268835B1 Retinoic acid receptor beta-2 and gene therapy vectors for the treatment of neurological disorders |
| 01/16/2008 | EP1204626B1 Ether compounds, compositions, and uses thereof |
| 01/16/2008 | EP1032587B1 Novel exendin agonist compounds |
| 01/16/2008 | EP1019073B1 Apolipoprotein a-i agonists and their use to treat dyslipidemic disorders |
| 01/16/2008 | CN101107247A Substituted benzoquinolizines as dpp-iv inhibitors for the treatment of diabetes |
| 01/16/2008 | CN101107239A N-[(4, 5-diphenyl-3-alkyl-2-thienyl) methyl] amine (amide, sulfonamide, carbamate and urea) derivatives as cannabinoid CB1 receptor antagonists |
| 01/16/2008 | CN101107235A Morpholines as 5HT2C agonists |
| 01/16/2008 | CN101107227A 5-aminoindole derivatives |
| 01/16/2008 | CN101107222A Substituted aminomethylene sulphonamides, production and use thereof as medicaments |
| 01/16/2008 | CN101106988A Formulations and dosing regimen for PPAR-alpha modulators |
| 01/16/2008 | CN101106987A Metabolic syndrome-improving agent and medicine, supplement, functional food and food additive containing the same |
| 01/16/2008 | CN101106986A Metabolic syndrome-improving agent and medicine, supplement, functional food and food additive containing the same |
| 01/16/2008 | CN101106914A Novel nutraceutical compositions |
| 01/16/2008 | CN101104860A Pupa cordyceps double-enzyme hydrolysis extraction technique |
| 01/16/2008 | CN101104618A Long chain alkyl berberine salt derivative, synthetic method and use |
| 01/16/2008 | CN101104029A Medicinal compositions |
| 01/16/2008 | CN101104013A Preparation of traditional Chinese medicine active component for treating diabetes and application thereof |
| 01/16/2008 | CN101104012A Medicine for treating cardiovascular disease |
| 01/16/2008 | CN101104010A Extracting and purifying technology for haw flavonoids substances |
| 01/16/2008 | CN101103996A Electrolyte nutrition intensifier |
| 01/16/2008 | CN101103995A Application of fly maggot chitosan in preparing regulating blood sugar product |
| 01/16/2008 | CN101103993A Hypoglycemic medicine composition |
| 01/16/2008 | CN101103991A Chickweed flavonoside extract, its preparation method and medicine made therefrom application |
| 01/16/2008 | CN101103990A Composition containing sulfonylureas sugar-reducing drug and statins lipid-lowering drug |
| 01/16/2008 | CN101103983A Medicinal composition stabilized by base reagent containing pitavastatin calcium and preparation technology thereof |
| 01/16/2008 | CN101103977A 糖尿病治疗药 Diabetic medicine |
| 01/16/2008 | CN101103966A Omega-3 falty acid-garlic oil capsule and manufacturing method thereof |
| 01/16/2008 | CN101103819A Selenium germanium peptide biscuit |
| 01/16/2008 | CN101103757A Buckwheat flower tea and its preparing process |
| 01/16/2008 | CN101103755A Method for producing convenient nutritive rice-tea and product |
| 01/16/2008 | CN101103752A Bamboo charcoal bag health-care tea |
| 01/16/2008 | CN100362091C A selenium yeast product, a method of preparing a selenium yeast product and the use of the product for preparing food, a dietary supplement or a drug |
| 01/16/2008 | CN100361992C Sulfonamide substituted xanthine derivatives for use as PEPCK inhibitors |